Creotech Instruments SA (CRI)

Key statistics

The key numbers describing the company and its stock. The descriptions below explain what each metric means — this is information, not a recommendation.

Market cap Total market value of all the company's shares: 2.61BPLN
P/E Ratio How much investors pay for 1 unit of the company's annual profit: 124.05
Forward P/E P/E based on the forecasted profit for next year: 0
Earnings Per Share (EPS) The company's profit attributable to a single share: 7.36PLN
Dividend Yield Annual dividend as a percentage of the share price: 0.00%
Beta How strongly the price swings relative to the whole market (1 = same as the market): 0.25
52-Week Low / 52-Week High The lowest and highest price over the last 12 months: 275.5 — 1086PLN
MA 50 The average price over the last 50 trading sessions: 719.2
MA 200 The average price over the last 200 trading sessions: 504.34
Profit Margin What percentage of revenue the company keeps as profit: 9.05%
ROE How much profit the company generates from its owners' capital: 17.33%
Sector: Industrials
Industry: Aerospace & Defense

Sector comparison

We compare this company with the typical (middle) company in the same industry to show how it looks against similar businesses. This is information, not a recommendation.

Industrials · 700 peers in sector

Metric	CRI	Sector median	Vs. industry
P/E	124.05	27.18	↑ Above average
EPS	7.36 PLN	0.31 PLN	↑ Above average
Dividend yield	0.00%	0.00%
Profit margin	9.05%	1.69%	↑ Above average
ROE	17.33%	3.80%	↑ Above average

Higher and lower here are only a comparison with the typical company in the industry — a higher or lower value on its own does not mean better or worse.

Latest news

RYVU THERAPEUTICS S.A.: Dane kliniczne romacyklibu zaprezentowane podczas Kongresu Europejskiego Stowarzyszenia Hematologicznego (EHA) 2026 / Clinical data on romaciclib presented at the 2026 European Hematology Association Congress
bankier.pl 6/11/2026
SpaceX rozgrzewa rynek do czerwowności. Drożeją też Creotech i Scanway
parkiet.com 6/11/2026
Analizy rynkowe
parkiet.com 6/11/2026
Creotech Instruments pozyskał 481 mln zł w ABB, środki wesprą realizację strategii rozwoju
inwestycje.pl 6/9/2026
Creotech sprzedał akcje w ABB. Inwestorzy dopisali
parkiet.com 6/9/2026

Financial statements & historical data

Income statements, balance sheets, cash flow, earnings and dividend history are available for registered users

AI Summary

AI-generated company analysis is available for registered users.

Where does this data come from?

Frequently Asked Questions

What is Creotech Instruments SA?

Creotech Instruments SA (CRI) is a publicly traded company. Find detailed information on this page.

Are Creotech Instruments SA shares expensive?

The price-to-earnings (P/E) ratio of Creotech Instruments SA is 124.05 — the share price is 124.05 times the annual profit per share. That is higher than the typical company in the same industry (industry median: 27.18). This is information, not a recommendation. (as of 2026-06-02)

How big is Creotech Instruments SA?

The market capitalization of Creotech Instruments SA — the combined value of all its shares — is 2.61 B PLN. The higher the market cap, the larger the company. (as of 2026-06-02)

Does Creotech Instruments SA pay dividends?

The dividend yield of Creotech Instruments SA is 0.00% — it shows the annual dividend relative to the share price. This is information, not a recommendation. (as of 2026-06-02)

What sector does Creotech Instruments SA belong to?

Creotech Instruments SA operates in the Industrials sector, industry: Aerospace & Defense.